Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening-Reference-Cited by-同舟云学术

Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening

Published:2017-11-14 Issue:5 Volume:110 Page:501-508
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Schiffman Mark¹,Kinney Walter K²,Cheung Li C¹,Gage Julia C¹,Fetterman Barbara²,Poitras Nancy E²,Lorey Thomas S²,Wentzensen Nicolas¹,Befano Brian³,Schussler John³,Katki Hormuzd A¹,Castle Philip E⁴

Affiliation:

1. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD

2. Regional Laboratory, The Permanente Medical Group, Oakland, CA

3. Information Management Services, Calverton, MD

4. Albert Einstein College of Medicine, Bronx, NY

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/110/5/501/24797249/djx225.pdf

Reference44 articles.

1. Human papillomavirus and cervical cancer;Schiffman;Lancet.,2007

2. Overview of the European and North American studies on HPV testing in primary cervical cancer screening;Cuzick;Int J Cancer.,2006

3. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer;Mayrand;N Engl J Med.,2007

4. Human papillomavirus and Papanicolaou tests to screen for cervical cancer;Naucler;N Engl J Med.,2007

5. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: Final results of the POBASCAM randomised controlled trial;Rijkaart;Lancet Oncol.,2012

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States;American Journal of Obstetrics and Gynecology;2024-02

2. The evolution of cervical cancer screening;Journal of the American Society of Cytopathology;2024-01

3. Tritesting in Battor, Ghana: an integrated cervical precancer screening strategy to mitigate the challenges of multiple screening visits and loss to follow-up;ecancermedicalscience;2023-12-08

4. Efficacy of Cobas HPV testing for predicting grade 2+ cervical intraepithelial neoplasia in a cancer prevention center and a gynecologic oncology clinic: A single‐institution experience;Cancer Cytopathology;2023-12-06

5. Zervixkarzinomprävention durch HPV-Impfung und Früherkennung;Die Gynäkologie;2023-11-09